Home > PE Ratio > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
PE (Price/Earnings) Ratio

The Current P/E Ratio of SAMRAT PHARMACHEM is 43.16.

Share Price ₹218.5Feb 04,2026
Market Cap ₹67.7 Cr
Earnings-TTM₹1.6 CrTTM-Standalone Results
Price/Earnings43.16xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SAMRAT PHARMACHEM

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SAMRAT PHARMACHEM is calculated as :

Current Market Cap [ ₹67.7 Cr] as on Feb 04,2026

(/) Earnings [ ₹1.6 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 43.16x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SAMRAT PHARMACHEM , the investors are currently willing to pay 43.16 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAMRAT PHARMACHEM !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SAMRAT PHARMACHEM over the last five years.

Historical PE (Price/Earnings) ratio chart of SAMRAT PHARMACHEM


PE Ratio Performance Analysis for SAMRAT PHARMACHEM

- SAMRAT PHARMACHEM 's latest p/e ratio is 43.16x.

- SAMRAT PHARMACHEM 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 16.94x.

- SAMRAT PHARMACHEM 's operated at median p/e ratio of 8.72x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SAMRAT PHARMACHEM 's p/e ratio peaked in Mar2024 at 47.64x.

- SAMRAT PHARMACHEM 's p/e ratio hit its five-year low in Mar2023 of 6.89x.


How does SAMRAT PHARMACHEM 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SAMRAT PHARMACHEM 1.5743.1667.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4037.16408,847.0
DIVIS LABORATORIES LTD2,485.0064.69160,745.0
CIPLA LTD4,544.7023.56107,075.0
TORRENT PHARMACEUTICALS LTD2,140.0063.71136,346.0
DR REDDYS LABORATORIES LTD5,508.7018.79103,507.0
MANKIND PHARMA LTD1,796.6548.0186,263.9
ZYDUS LIFESCIENCES LTD4,973.4018.3191,069.2
LUPIN LTD4,347.5323.07100,286.0
AUROBINDO PHARMA LTD3,447.7520.4170,375.7
ABBOTT INDIA LTD1,508.9538.1957,623.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAMRAT PHARMACHEM 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.31x
Max industry PE 64.69x
Median industry PE 37.16x
Average industry PE 36.28x



You may also like the below Video Courses